$15.03
1.83% yesterday
NYSE, Nov 15, 10:00 pm CET
ISIN
US68622V1061
Symbol
OGN

Organon & Co. Target price 2024 - Analyst rating & recommendation

Organon & Co. Classifications & Recommendation:

Buy
33%
Hold
44%
Sell
22%

Organon & Co. Price Target

Target Price $22.38
Price $15.03
Potential
Number of Estimates 8
8 Analysts have issued a price target Organon & Co. 2025 . The average Organon & Co. target price is $22.38. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 3 Analysts recommend Organon & Co. to buy, 4 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Organon & Co. stock has an average upside potential 2025 of . Most analysts recommend the Organon & Co. stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 6.26 6.39
1.44% 2.05%
EBITDA Margin 24.96% 30.40%
20.21% 21.81%
Net Margin 16.41% 15.54%
9.56% 5.29%

7 Analysts have issued a sales forecast Organon & Co. 2024 . The average Organon & Co. sales estimate is

$6.4b
Unlock
. This is
0.27% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.4b 0.40%
Unlock
, the lowest is
$6.4b 0.92%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $6.3b 1.44%
2024
$6.4b 2.05%
Unlock
2025
$6.5b 2.13%
Unlock
2026
$6.5b 0.01%
Unlock
2027
$6.2b 5.11%
Unlock
2028
$6.2b 0.00%
Unlock

6 Analysts have issued an Organon & Co. EBITDA forecast 2024. The average Organon & Co. EBITDA estimate is

$1.9b
Unlock
. This is
10.27% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$2.0b 13.14%
Unlock
, the lowest is
$1.9b 6.02%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $1.6b 19.06%
2024
$1.9b 24.31%
Unlock
2025
$2.0b 1.47%
Unlock
2026
$2.0b 3.90%
Unlock

EBITDA Margin

2023 24.96% 20.21%
2024
30.40% 21.81%
Unlock
2025
30.20% 0.66%
Unlock
2026
31.38% 3.91%
Unlock

4 Organon & Co. Analysts have issued a net profit forecast 2024. The average Organon & Co. net profit estimate is

$993m
Unlock
. This is
23.46% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.1b 18.25%
Unlock
, the lowest is
$909m 29.96%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $1.0b 11.14%
2024
$993m 3.32%
Unlock
2025
$1.0b 5.51%
Unlock
2026
$1.1b 3.79%
Unlock
2027
$1.2b 7.00%
Unlock

Net Margin

2023 16.41% 9.56%
2024
15.54% 5.29%
Unlock
2025
16.06% 3.35%
Unlock
2026
16.66% 3.74%
Unlock
2027
18.79% 12.79%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 3.99 3.86
11.14% 3.26%
P/E 3.90
EV/Sales 1.86

4 Analysts have issued a Organon & Co. forecast for earnings per share. The average Organon & Co. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$3.86
Unlock
. This is
23.41% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$4.12 18.25%
Unlock
, the lowest is
$3.53 29.96%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $3.99 11.14%
2024
$3.86 3.26%
Unlock
2025
$4.07 5.44%
Unlock
2026
$4.22 3.69%
Unlock
2027
$4.52 7.11%
Unlock

P/E ratio

Current 2.98 38.81%
2024
3.90 30.87%
Unlock
2025
3.69 5.38%
Unlock
2026
3.56 3.52%
Unlock
2027
3.33 6.46%
Unlock

Based on analysts' sales estimates for 2024, the Organon & Co. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.85 2.78%
2024
1.86 0.27%
Unlock
2025
1.82 2.09%
Unlock
2026
1.82 0.01%
Unlock
2027
1.91 5.39%
Unlock
2028
1.91 0.00%
Unlock

P/S ratio

Current 0.60 30.68%
2024
0.61 0.26%
Unlock
2025
0.59 2.08%
Unlock
2026
0.59 0.02%
Unlock
2027
0.62 5.38%
Unlock
2028
0.62 0.00%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today